Zoetis Inc.
ZTSDrug Manufacturers - Specialty & Generic
$79.72+1.17%As of Oct 30vs prior close
- Market cap
- $32.9B
- P/E (TTM)
- 12.5×
- From 52W high
- −43.91%
- EPS (LTM)
- $6.12
- Revenue (LTM)
- $9.5B
- Net margin
- 27.69%
- Dividend yield
- 2.62%
Nomior Score
44
Steady ProfileBottom 37% of the scored universe
Growth26
Quality84
Value63
Momentum3
Resilience60
Growth
+7.62%revenue a year over 9 fiscal years
YE16 $4.9BLTM $9.5B
Connections
Revenue to profitQ2 YE26
28% of revenue became net profit, down 1 pt on a year.
Who owns it
6funds, 6 tracked portfolios